Literature DB >> 17216187

Expression of p53/HGF/c-met/STAT3 signal in fetuses with neural tube defects.

Maria Trovato1, Maria D'Armiento, Luca Lavra, Alessandra Ulivieri, Roberto Dominici, Enrica Vitarelli, Maddalena Grosso, Raffaella Vecchione, Gaetano Barresi, Salvatore Sciacchitano.   

Abstract

Neural tube defects (NTD) are morphogenetic alterations due to a defective closure of neural tube. Hepatocyte growth factor (HGF)/c-met system plays a role in morphogenesis of nervous system, lung, and kidney. HGF/c-met morphogenetic effects are mediated by signal transducers and activators of transcription (STAT)3 and both HGF and c-met genes are regulated from p53. The aim of our study was to analyze mRNA and protein expressions of p53, HGF, c-met, and STAT3 in fetuses with NTD. By reverse transcriptase-polymerase chain reaction and immunohistochemistry, we analyzed neural tissues from four NTD fetuses and the corresponding non-malformed lungs, kidneys and placentas. We found a reduced mRNA expression of HGF/c-met/STAT3 pathway, in the malformed nervous systems and placentas. The reduced expression of this pathway correlated with the absence of p53 in all these samples. On the contrary, detectable expression levels of p53, HGF, c-met, and STAT3 were observed in non-malformed lungs and kidneys obtained from the same fetuses. Comparable results were obtained by immunohistochemistry, with the exception of p53, which was undetected in all fetal tissues. In conclusion, in NTD fetuses, both the defective neural tube tissue and the placenta have a reduction in all components of the p53/HGF/c-met/STAT3 cascade. This raises the possibility of using the suppression of these genes for early diagnosis of NTD especially on chorionic villus sampling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216187     DOI: 10.1007/s00428-006-0356-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter.

Authors:  A M Metcalfe; R M Dixon; G K Radda
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

2.  An in vitro tubulogenesis system using cell lines derived from the embryonic kidney shows dependence on multiple soluble growth factors.

Authors:  H Sakurai; E J Barros; T Tsukamoto; J Barasch; S K Nigam
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 3.  Neural tube defects.

Authors:  R J Lemire
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272

4.  The development of the human brain, the closure of the caudal neuropore, and the beginning of secondary neurulation at stage 12.

Authors:  F Müller; R O'Rahilly
Journal:  Anat Embryol (Berl)       Date:  1987

Review 5.  Apparent lability of neural tube closure in laboratory animals and humans.

Authors:  J M DeSesso; A R Scialli; J F Holson
Journal:  Am J Med Genet       Date:  1999-11-19

Review 6.  A review of the theories of vertebrate neurulation and their relationship to the mechanics of neural tube birth defects.

Authors:  R Gordon
Journal:  J Embryol Exp Morphol       Date:  1985-11

7.  Prevalence of neural tube defects in 16 regions of Europe, 1980-1983. The EUROCAT Working Group.

Authors: 
Journal:  Int J Epidemiol       Date:  1987-06       Impact factor: 7.196

8.  Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor.

Authors:  Y Uehara; O Minowa; C Mori; K Shiota; J Kuno; T Noda; N Kitamura
Journal:  Nature       Date:  1995-02-23       Impact factor: 49.962

Review 9.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.

Authors:  R Zarnegar; G K Michalopoulos
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

10.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

Authors:  L Naldini; K M Weidner; E Vigna; G Gaudino; A Bardelli; C Ponzetto; R P Narsimhan; G Hartmann; R Zarnegar; G K Michalopoulos
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  2 in total

1.  MicroRNA gene expression signatures in the developing neural tube.

Authors:  Partha Mukhopadhyay; Guy Brock; Savitri Appana; Cynthia Webb; Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-07-18

2.  The tumour-suppressor p53 is not required for pancreatic beta cell death during diabetes and upon irradiation.

Authors:  Shin Yuen Nam; Ming Kei Lee; Kanaga Sabapathy
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.